NO991407D0 - Legemiddelaerosolformuleringer som omfatter budesonid - Google Patents

Legemiddelaerosolformuleringer som omfatter budesonid

Info

Publication number
NO991407D0
NO991407D0 NO991407A NO991407A NO991407D0 NO 991407 D0 NO991407 D0 NO 991407D0 NO 991407 A NO991407 A NO 991407A NO 991407 A NO991407 A NO 991407A NO 991407 D0 NO991407 D0 NO 991407D0
Authority
NO
Norway
Prior art keywords
budesonide
aerosol formulations
drug aerosol
drug
formulations
Prior art date
Application number
NO991407A
Other languages
English (en)
Other versions
NO991407L (no
Inventor
Nayna Govind
Philip A Jinks
Danna L Ross
Gary Ward
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991407(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NO991407D0 publication Critical patent/NO991407D0/no
Publication of NO991407L publication Critical patent/NO991407L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO991407A 1996-09-27 1999-03-23 Legemiddelaerosolformuleringer som omfatter budesonid NO991407L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9620187.6A GB9620187D0 (en) 1996-09-27 1996-09-27 Medicinal aerosol formulations
PCT/US1997/016869 WO1998013031A2 (en) 1996-09-27 1997-09-23 Medicinal aerosol formulations comprising budesonide

Publications (2)

Publication Number Publication Date
NO991407D0 true NO991407D0 (no) 1999-03-23
NO991407L NO991407L (no) 1999-03-23

Family

ID=10800599

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991407A NO991407L (no) 1996-09-27 1999-03-23 Legemiddelaerosolformuleringer som omfatter budesonid

Country Status (21)

Country Link
EP (1) EP0932397B2 (no)
JP (1) JP2001501209A (no)
KR (1) KR20000048646A (no)
AR (1) AR009370A1 (no)
AT (1) ATE320246T1 (no)
AU (1) AU732985B2 (no)
BR (1) BR9712125A (no)
CA (1) CA2266431A1 (no)
CZ (1) CZ102799A3 (no)
DE (1) DE69735497T2 (no)
ES (1) ES2259447T3 (no)
GB (1) GB9620187D0 (no)
HU (1) HUP0000795A3 (no)
ID (1) ID22523A (no)
MY (1) MY130946A (no)
NO (1) NO991407L (no)
PL (1) PL332422A1 (no)
PT (1) PT932397E (no)
SK (1) SK38399A3 (no)
WO (1) WO1998013031A2 (no)
ZA (1) ZA978303B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
HU230804B1 (hu) 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ES2317306T3 (es) 2004-10-12 2009-04-16 Generics (Uk) Limited Procedimiento para la preparacion de formulaciones en aerosol en suspension, en el que las particulas se forman por precipitacion dentro de un frasco de aerosol.
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
CN102362859A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN103655473A (zh) * 2011-10-27 2014-03-26 江苏长风药业有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) * 2018-12-25 2019-04-19 上海信谊百路达药业有限公司 一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) * 2021-10-25 2023-05-09 上海方予健康医药科技有限公司 新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) * 1990-06-04 1992-08-04 Ethyl Corporation Process for halogenating aromatic compounds
EP0504112A3 (en) † 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
NZ246421A (en) † 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
DE4230876A1 (de) † 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE69413955T2 (de) * 1993-03-17 1999-04-01 Minnesota Mining & Mfg Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (no) * 1993-09-24 1996-08-11 Du Pont
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) † 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
NZ298169A (en) * 1994-12-22 1999-09-29 Astra Ab Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant

Also Published As

Publication number Publication date
GB9620187D0 (en) 1996-11-13
EP0932397A2 (en) 1999-08-04
CA2266431A1 (en) 1998-04-02
EP0932397B1 (en) 2006-03-15
AU4492697A (en) 1998-04-17
ID22523A (id) 1999-10-28
PT932397E (pt) 2006-07-31
AU732985B2 (en) 2001-05-03
BR9712125A (pt) 1999-08-31
WO1998013031A3 (en) 1998-08-27
DE69735497D1 (de) 2006-05-11
MY130946A (en) 2007-07-31
ATE320246T1 (de) 2006-04-15
SK38399A3 (en) 1999-09-10
NO991407L (no) 1999-03-23
DE69735497T2 (de) 2006-08-24
CZ102799A3 (cs) 1999-07-14
PL332422A1 (en) 1999-09-13
ZA978303B (en) 1999-03-15
WO1998013031A2 (en) 1998-04-02
ES2259447T3 (es) 2006-10-01
HUP0000795A3 (en) 2000-09-28
KR20000048646A (ko) 2000-07-25
HUP0000795A2 (hu) 2000-08-28
AR009370A1 (es) 2000-04-12
EP0932397B2 (en) 2014-04-02
JP2001501209A (ja) 2001-01-30

Similar Documents

Publication Publication Date Title
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
DE69530325D1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO985720L (no) Aerosol legemiddelformuleringer av formoterol
ID24654A (id) Formulasi farmasi omeprazola
NO990956L (no) Klorfluorkarbonfrie mometasonfuroataerosolpreparater
ID16781A (id) Formulasi-formulasi farmasi
TR199501082A2 (tr) Farmasötik formülasyonlar.
ITMI941169A0 (it) Formulazioni farmaceutiche
ID25972A (id) Formulasi aerosol pestisida
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9404469D0 (sv) Aerosol formulations
SE9502452D0 (sv) Aerosol formulations
GB9814709D0 (en) Pharmaceutical aerosol formulation
GB9808152D0 (en) Pharmaceutical aerosol formulation
SI1073417T1 (en) Pharmaceutical aerosol formulation
SE9600141D0 (sv) Pharmaceutical formulation
IT240679Y1 (it) Spaziatore per la somministrazione di aerosol pre-dosato a volumevariabile

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application